International – WHO warns against indiscriminate use of dexamethasone

The World Health Organization (WHO) on Wednesday said a common drug shown to be effective in treating COVID-19 is meant for use only among those who are suffering the most severe symptoms of the disease, not those who have milder cases.

Scientists at the University of Oxford said Tuesday that their studies had showed dexamethasone was effective in reducing the mortality rate of severely ill patients. The study is the first to show that an already available drug is effective in reducing death rates among COVID-19 patients.

Dexamethasone is a steroid. It appears to reduce inflammation in the lungs, an immune system response that can damage tissue and hinder the body’s ability to absorb oxygen. Reducing inflammation gives a patient’s immune system a window of time in which to fight back against the disease…